Bifidobacterium longum Suppresses Murine Colorectal Cancer through the Modulation of oncomiRs and Tumor Suppressor miRNAs

References

• Sears CL and Garrett WS: Microbes, microbiota, and colon cancer. Cell Host Microbe 15, 317–328, 2014.
   PubMed Web of Science ®Google Scholar
• Loftus EV, Jr.: Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126, 1504–1517, 2004.
   PubMed Web of Science ®Google Scholar
• Itzkowitz SH and Present DH: Crohn’s and Colitis Foundation of America Colon Cancer in IBD Study Group. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 11, 314–321, 2005.
   PubMed Web of Science ®Google Scholar
• Sartor RB: Review article: role of the enteric microflora in the pathogenesis of intestinal inflammation and arthritis. Aliment Pharmacol 11, 17–23, 2010.
   Google Scholar
• Gibson GR and Fuller R: Aspects of in vitro and in vivo research approaches directed toward identifying probiotics and prebiotics for human use. J Nutr 130, 391S–395S, 2000.
   PubMed Web of Science ®Google Scholar
• Venturi A, Gionchetti P, Rizzello F, Johansson R, and Zucconi E: Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment Pharmacol Ther 13, 1103–1108, 1999.
   PubMed Web of Science ®Google Scholar
• Davis CD and Milner JA: Gastrointestinal microflora, food components and colon cancer prevention. J Nutr Biochem 20, 743–752, 2009.
   PubMed Web of Science ®Google Scholar
• Rafter J: The effects of probiotics on colon cancer development. Nutr Res Rev 17, 277–284, 2004.
   PubMed Web of Science ®Google Scholar
• Wu QB, Sheng X, Zhang N, Yang MW, and Wang F: Role of microRNAs in the resistance of colorectal cancer to chemoradiotherapy. Mol Clin Oncol 8, 528–532, 2018.
   PubMed Web of Science ®Google Scholar
• Aslam MI, Hussein S, West K, Singh B, Jameson JS, et al.: MicroRNAs associated with initiation and progression of colonic polyp: a feasibility study. Int J Surg 13, 272–279, 2015.
   PubMed Web of Science ®Google Scholar
• Okayama H, Schetter AJ, and Harris CC: MicroRNAs and inflammation in the pathogenesis and progression of colon cancer. Dig Dis 30, 9–15, 2012.
   PubMed Web of Science ®Google Scholar
• Zhai H and Ju J: Implications of microRNAs in colorectal cancer development, diagnosis, prognosis, and therapeutics. Front Genet 2, 78–82, 2011.
   Google Scholar
• Orrhage K, Brismar B, and Nord CE: Effect of Supplements with Bifidobacterium longum and Lactobacillus acidophilus on the Intestinal Microbiota during Administration of Clindamycin. Microb. Ecol Health Dis 7, 17–25, 1994.
   Web of Science ®Google Scholar
• Cross ML, Ganner A, Teilab D, and Fray LM: Patterns of cytokine induction by Gram-positive and Gram-negative probiotic bacteria. FEMS Immunol Med Microbiol 42, 173–180, 2004.
   PubMed Web of Science ®Google Scholar
• Martín R, Jiménez E, Heilig H, Fernández L, Marín ML, et al.: Isolation of bifidobacteria from breast milk and assessment of the bifidobacterial population by PCR-denaturing gradient gel electrophoresis and quantitative real-time PCR. Appl Environ Microbiol 75, 965–969, 2009.
   PubMed Web of Science ®Google Scholar
• Turroni F, Marchesi JR, Foroni E, Gueimonde M, Shanahan F, et al.: Microbiomic analysis of the bifidobacterial population in the human distal gut. ISME J 3, 745–751, 2009.
   PubMed Web of Science ®Google Scholar
• Turroni F, Foroni E, Pizzetti P, Giubellini V, Ribbera A, et al.: Exploring the diversity of the bifidobacterial population in the human intestinal tract. Appl Environ Microbiol 75, 1534–1545, 2009.
   PubMed Web of Science ®Google Scholar
• Suzuki R, Kohno H, Sugie S, and Tanaka T: Dose-dependent promoting effect of dextran sodium sulfate on mouse colon carcinogenesis initiated with azoxymethane. Histol Histopathol 20, 483–492, 2005.
   PubMed Web of Science ®Google Scholar
• Roncucci L, Stamp D, Medline A, Cullen JB, and Bruce WR: Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol 22, 287–294, 1991.
   PubMed Web of Science ®Google Scholar
• Bustin SA: A-Z of Quantitative PCR. La Jolla, CA: International University Line, 2004-2006.
   Google Scholar
• Zhang B, Pan X, Cobb GP, and Anderson TA: MicroRNAs as oncogenes and tumor suppressors. Dev Biol 302, 1–12, 2007.
   PubMed Web of Science ®Google Scholar
• Krichevsky AM and Gabriely G: MiR-21: a small multi-faceted RNA. J Cell Mol Med 13, 39–53, 2009.
   PubMed Web of Science ®Google Scholar
• Valeri N, Gasparini P, Braconi C, Paone A, Lovat F, et al.: MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2). Proc Natl Acad Sci USA 107, 21098–21103, 2010.
   PubMed Web of Science ®Google Scholar
• Terao M, Fratelli M, Kurosaki M, Zanetti A, Guarnaccia V, et al.: Induction of miR-21 by retinoic acid in estrogen receptor-positive breast carcinoma cells: biological correlates and molecular targets. J Biol Chem 286, 4027–4042, 2011.
   PubMed Web of Science ®Google Scholar
• Sachdeva M, Zhu S, Wu F, Wu H, Walia V, et al.: P53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci USA 106, 3207–3212, 2009.
   PubMed Web of Science ®Google Scholar
• Quinn SR and O’Neill LA: A trio of microRNAs that control Toll-like receptor signalling. Int Immunol 23, 421–510, 2011.
   PubMed Web of Science ®Google Scholar
• Valmiki S, Ahuja V, and Paul J: MicroRNA exhibit altered expression in the inflamed colonic mucosa of ulcerative colitis patients. World J Gastroenterol 23, 5324–5332, 2017.
   PubMed Web of Science ®Google Scholar
• Qu Y-L, Wang H-F, Sun Z-Q, Tang Y, Han X-N, et al.: Up-regulated miR-155-5p promotes cell proliferation, invasion and metastasis in colorectal carcinoma. Int J Clin Exp Pathol 8, 6988–6994, 2015.
   PubMed Web of Science ®Google Scholar
• Pagliuca A, Valvo C, Fabrizi E, Di Martino S, Biffoni M, et al.: Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression. Oncogene 32, 4806–4813, 2013.
   PubMed Web of Science ®Google Scholar
• Yu Y, Nangia-Makker P, Farhana L, G Rajendra S, Levi E, et al.: MiR-21 and miR-145 cooperation in regulation of colon cancer stem cells. Mol Cancer 14, 98, 2015.
   PubMed Web of Science ®Google Scholar
• Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, et al.: MiR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102, 13944–13949, 2005.
   PubMed Web of Science ®Google Scholar
• Fesler A, Liu H, and Ju J: Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1. Oncotarget 9, 2367–2383, 2018.
   PubMedGoogle Scholar
• Rusca N and Monticelli S: MiR-146a in immunity and disease. Mol Biol Int 2011, 437301, 2011.
   PubMedGoogle Scholar
• Lu D, Yao Q, Zhan C, Le-Meng Z, Liu H, et al.: MicroRNA-146a promote cell migration and invasion in human colorectal cancer via carboxypeptidase M/src-FAK pathway. Oncotarget 8, 22674–22684, 2017.
   PubMedGoogle Scholar
• Zhou J, Chaudhry H, Zhong Y, Ali MM, Perkins LA, et al.: Dysregulation in microRNA expression in peripheral blood mononuclear cells of sepsis patients is associated with immunopathology. Cytokine 71, 89–100, 2015.
   PubMed Web of Science ®Google Scholar
• Qian BZ and Pollard JW: Macrophage diversity enhances tumor progression and metastasis. Cell 141, 39–51, 2010.
   PubMed Web of Science ®Google Scholar
• Grivennikov S, Karin E, Terzic J, Mucida D, Yu GY, et al.: IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15, 103–113, 2009.
   PubMed Web of Science ®Google Scholar
• Park SY, Ji GE, Ko YT, Jung HK, Ustunol Z, et al.: Potentiation of hydrogen peroxide, nitric oxide, and cytokine production in RAW 264.7 macrophage cells exposed to human and commercial isolates of Bifidobacterium. Int J Food Microbiol 46, 231–241, 1999.
   PubMed Web of Science ®Google Scholar
• Furrie E, Macfarlane S, Kennedy A, Cummings JH, Walsh SV, et al.: Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 54, 242–249, 2005.
   PubMed Web of Science ®Google Scholar
• Dolcet X, Llobet D, Pallares J, and Matias-Guiu X: NF-kB in development and progression of human cancer. Virchows Arch 446, 475–482, 2005.
   PubMed Web of Science ®Google Scholar